Real-World Metastatic Renal Cell Carcinoma Treatment Patterns and Clinical Outcomes in The Netherlands

The number of treatment options for patients with metastatic renal cell carcinoma (mRCC) has significantly grown in the last 15 years. Although randomized controlled trials are fundamental in investigating mRCC treatment efficacy, their external validity can be limited. Therefore, the efficacy of th...

Descripción completa

Detalles Bibliográficos
Autores principales: van Laar, S.A., Gombert-Handoko, K.B., Groenwold, R.H.H., van der Hulle, T., Visser, L.E., Houtsma, D., Guchelaar, H.J., Zwaveling, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983834/
https://www.ncbi.nlm.nih.gov/pubmed/35401238
http://dx.doi.org/10.3389/fphar.2022.803935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8983834/
https://www.ncbi.nlm.nih.gov/pubmed/35401238
http://dx.doi.org/10.3389/fphar.2022.803935

Ejemplares similares